In the last trading session, 5.96 million Sana Biotechnology Inc (NASDAQ:SANA) shares changed hands as the company’s beta touched 1.86. With the company’s per share price at $2.81 changed hands at -$0.06 or -2.09% during last session, the market valuation stood at $633.81M. SANA’s last price was a discount, traded about -163.35% off its 52-week high of $7.40. The share price had its 52-week low at $1.26, which suggests the last value was 55.16% up since then. When we look at Sana Biotechnology Inc’s average trading volume, we note the 10-day average is 5.96 million shares, with the 3-month average coming to 4.05 million.
Analysts gave the Sana Biotechnology Inc (SANA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.29. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SANA as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Instantly SANA was in red as seen at the end of in last trading. With action 7.66%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -48.15%, with the 5-day performance at 7.66% in the green. However, in the 30-day time frame, Sana Biotechnology Inc (NASDAQ:SANA) is 24.89% up. Looking at the short shares, we see there were 43.56 million shares sold at short interest cover period of 11.2 days.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 64.88% from its current market value. According to analyst projections, SANA’s forecast low is 8 with 8 as the target high. To hit the forecast high, the stock’s price needs a -184.7% plunge from its current level, while the stock would need to soar -184.7% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -10.60%. The 2025 estimates are for Sana Biotechnology Inc earnings to increase by 34.68%, but the outlook for the next 5-year period is at 14.07% per year.
SANA Dividends
Sana Biotechnology Inc is expected to release its next quarterly earnings report on 2025-May-08.
Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 8.46% of Sana Biotechnology Inc shares while 89.39% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 97.65%. There are 89.39% institutions holding the Sana Biotechnology Inc stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 11.5894% of the shares, roughly 27.17 million SANA shares worth $148.35 million.
FLAGSHIP PIONEERING INC. holds the second largest percentage of outstanding shares, with 10.6645% or 25.0 million shares worth $136.51 million as of 2024-06-30.
